CoumestrolCAS# 479-13-0 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 479-13-0 | SDF | Download SDF |
PubChem ID | 5281707 | Appearance | White - brown powder |
Formula | C15H8O5 | M.Wt | 268.2 |
Type of Compound | Coumarins | Storage | Desiccate at -20°C |
Synonyms | Coumesterol | ||
Solubility | Soluble in DMSO; slightly soluble in chloroform, ethanol and methanol; insoluble in water | ||
Chemical Name | 3,9-dihydroxy-[1]benzofuro[3,2-c]chromen-6-one | ||
SMILES | C1=CC2=C(C=C1O)OC3=C2C(=O)OC4=C3C=CC(=C4)O | ||
Standard InChIKey | ZZIALNLLNHEQPJ-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C15H8O5/c16-7-1-3-9-11(5-7)19-14-10-4-2-8(17)6-12(10)20-15(18)13(9)14/h1-6,16-17H | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Coumestrol suppresses the accumulation of HIF-1α via suppression of SPHK1 pathway in hypoxic PC-3 cells. 2. Coumestrol is a novel inducer of mitochondrial biogenesis through the activation of Sirt1. 3. Coumestrol can function by inhibiting oncogenic disease, at least in part, through CKII inhibition-mediated cellular senescence. 4. Coumestrol treatment is effective in preventing neuronal loss in all times of administration as well as able to rescue the Na+, K+ -ATPase activity, suggesting its potential benefits for either prevention or therapeutics use against cerebral ischemia in males. |
Targets | HIF | Akt | GSK-3 | ROS | NADPH-oxidase | NOS | PKA | PI3K | ERK | cAMP | p53 | p21 | NADPH-oxidase | Estrogen receptor | Sodium Channel | ATPase | Potassium Channel | Progestogen receptor |
Coumestrol Dilution Calculator
Coumestrol Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.7286 mL | 18.6428 mL | 37.2856 mL | 74.5712 mL | 93.214 mL |
5 mM | 0.7457 mL | 3.7286 mL | 7.4571 mL | 14.9142 mL | 18.6428 mL |
10 mM | 0.3729 mL | 1.8643 mL | 3.7286 mL | 7.4571 mL | 9.3214 mL |
50 mM | 0.0746 mL | 0.3729 mL | 0.7457 mL | 1.4914 mL | 1.8643 mL |
100 mM | 0.0373 mL | 0.1864 mL | 0.3729 mL | 0.7457 mL | 0.9321 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Calcium-Sensing Receptor Antagonists I
Catalog No.:BCC1448
CAS No.:478963-79-0
- Angiotensin 1/2 (1-6)
Catalog No.:BCC1036
CAS No.:47896-63-9
- Zopfiellamide A
Catalog No.:BCN1865
CAS No.:478945-64-1
- Kisspeptin 10 (rat)
Catalog No.:BCC6132
CAS No.:478507-53-8
- CP 339818 hydrochloride
Catalog No.:BCC7048
CAS No.:478341-55-8
- ISO-1
Catalog No.:BCC5427
CAS No.:478336-92-4
- 4-Hydroxymethylphenol 1-O-rhamnoside
Catalog No.:BCN7750
CAS No.:478314-67-9
- Gabapentin enacarbil
Catalog No.:BCC4239
CAS No.:478296-72-9
- R-1479
Catalog No.:BCC1878
CAS No.:478182-28-4
- Isoerysenegalensein E
Catalog No.:BCN3978
CAS No.:478158-77-9
- PHA 543613 hydrochloride
Catalog No.:BCC5972
CAS No.:478149-53-0
- Pseudococaine
Catalog No.:BCN1902
CAS No.:478-73-9
- Dyphylline
Catalog No.:BCC2297
CAS No.:479-18-5
- Atranorin
Catalog No.:BCN5544
CAS No.:479-20-9
- Cotoin
Catalog No.:BCN5545
CAS No.:479-21-0
- Indirubin
Catalog No.:BCN2385
CAS No.:479-41-4
- Canthin-6-one
Catalog No.:BCN5546
CAS No.:479-43-6
- Artemetin
Catalog No.:BCN5547
CAS No.:479-90-3
- Vitexicarpin
Catalog No.:BCN5020
CAS No.:479-91-4
- Aucubin
Catalog No.:BCN5355
CAS No.:479-98-1
- [Orn8]-Urotensin II
Catalog No.:BCC5793
CAS No.:479065-85-5
- MMPIP hydrochloride
Catalog No.:BCC7528
CAS No.:479077-02-6
- TC OT 39
Catalog No.:BCC7958
CAS No.:479232-57-0
- CNQX disodium salt
Catalog No.:BCC6908
CAS No.:479347-85-8
Coumestrol suppresses hypoxia inducible factor 1alpha by inhibiting ROS mediated sphingosine kinase 1 in hypoxic PC-3 prostate cancer cells.[Pubmed:24768446]
Bioorg Med Chem Lett. 2014 Jun 1;24(11):2560-4.
Among many signals to regulate hypoxia inducible factor 1alpha (HIF-1alpha), sphingosine kinase 1 (SPHK1) is also involved in various biological activities such as cell growth, survival, invasion, angiogenesis, and carcinogenesis. Thus, in the present study, molecular mechanisms of Coumestrol were investigated on the SPHK1 and HIF-1alpha signaling pathway in hypoxic PC-3 prostate cancer cells. Coumestrol significantly suppressed SPHK1 activity and accumulation of HIF-1alpha in a time- and concentration-dependent manner in hypoxic PC-3 cells. In addition, Coumestrol inhibited the phosphorylation status of AKT and glycogen synthase kinase-3beta (GSK 3beta) signaling involved in cancer metabolism. Furthermore, SPHK1 siRNA transfection, sphigosine kinase inhibitor (SKI), reactive oxygen species (ROS) enhanced the inhibitory effect of Coumestrol on the accumulation of HIF-1alpha and the expression of pAKT and pGSK 3beta in hypoxic PC-3 cells by combination index. Overall, our findings suggest that Coumestrol suppresses the accumulation of HIF-1alpha via suppression of SPHK1 pathway in hypoxic PC-3 cells.
Coumestrol induces mitochondrial biogenesis by activating Sirt1 in cultured skeletal muscle cells.[Pubmed:24712520]
J Agric Food Chem. 2014 May 14;62(19):4298-305.
The mitochondrion is a central organelle in cellular energy homeostasis; thus, reduced mitochondrial activity has been associated with aging and metabolic disorders. This paper provides biological evidence that Coumestrol, which is a natural isoflavone, activates mitochondrial biogenesis. In cultured myocytes, Coumestrol activated the silent information regulator two ortholog 1 (Sirt1) through the elevation of the intracellular NAD(+)/NADH ratio. Coumestrol also increased the mitochondrial contents and induced the expression of key proteins in the mitochondrial electron transfer chain in cultured myocytes. A Sirt1 inhibitor and Sirt1-targeting siRNAs abolished the effect of Coumestrol on mitochondrial biogenesis. Similar to an increase in mitochondrial content, Coumestrol improved myocyte function with increased ATP concentration. Taken together, the data suggest that Coumestrol is a novel inducer of mitochondrial biogenesis through the activation of Sirt1.
Coumestrol inhibits carotid sinus baroreceptor activity by cAMP/PKA dependent nitric oxide release in anesthetized male rats.[Pubmed:25449602]
Biochem Pharmacol. 2015 Jan 1;93(1):42-8.
Phytoestrogens could offer multiple beneficial effects on the cardiovascular system. Here, we have examined the effects of Coumestrol (CMT) on carotid baroreceptors activity (CBA) and the possible mechanisms in male rats. The functional parameters of carotid baroreceptors were measured by recording sinus nerve afferent discharge in anesthetized male rats with perfused isolated carotid sinus. The levels of protein expression were determined by using ELISA and Western blotting. CMT (1 to 100mumolL(-1)) inhibited CBA, which shifted the functional curve of the carotid baroreceptor to the right and downward, with a marked decrease in the peak slope and the peak integral value of carotid sinus nerve discharge in a concentration dependent manner. These effects were not blocked by a specific estrogen receptor antagonist ICI 182,780, but were completely abolished by nitric oxide (NO) synthase inhibitor l-NAME (N(G)-nitro-l-arginine methyl ester). Furthermore, a NO donor, SIN-1(3-morpholion-sydnon-imine), could potentiate these inhibitory effects of CMT. CMT stimulated the phosphorylation of Ser(1176)-eNOS (endothelial nitric oxide synthase) in a dose-dependent manner in carotid bifurcation tissue over a perfusion period of 15min. The rapid activation of eNOS by CMT was blocked by a highly selective PKA (protein kinase A) inhibitor H89. In addition, inhibition of PI3K (phosphatidylinositol-3-kinase) and ERK (extracellular signal-regulated kinase) pathways had no effect on eNOS activation by CMT. CMT inhibited CBA via eNOS activation and NO synthesis. These effects were mediated by the cAMP/PKA pathway and were unrelated to the estrogenic effect.
Coumestrol induces senescence through protein kinase CKII inhibition-mediated reactive oxygen species production in human breast cancer and colon cancer cells.[Pubmed:23768371]
Food Chem. 2013 Nov 1;141(1):381-8.
An inhibitor of the protein kinase CKII (CKII) was purified from leaves of Glycine max (L.) Merrill and was identified as Coumestrol by structural analysis. Coumestrol inhibited the phosphotransferase activity of CKII toward beta-casein, with an IC50 of about 5 muM. It acted as a competitive inhibitor with respect to ATP as a substrate, with an apparent Ki value of 7.67 muM. Coumestrol at 50muM resulted in 50% and 30% growth inhibition of human breast cancer MCF-7 and colorectal cancer HCT116 cells, respectively. Coumestrol promoted senescence through the p53-p21(Cip1/WAF1) pathway by inducing reactive oxygen species (ROS) production in MCF-7 and HCT116 cells. The ROS scavenger N-acetyl-l-cysteine (NAC), NADPH oxidase inhibitor apocynin and p22(phox) siRNA almost completely abolished this event. Overexpression of CKIIalpha antagonised cellular senescence mediated by Coumestrol, indicating that this compound induced senescence via a CKII-dependent pathway. Since senescence is an important tumour suppression process in vivo, these results suggest that Coumestrol can function by inhibiting oncogenic disease, at least in part, through CKII inhibition-mediated cellular senescence.
Coumestrol treatment prevents Na+, K+ -ATPase inhibition and affords histological neuroprotection to male rats receiving cerebral global ischemia.[Pubmed:24512013]
Neurol Res. 2014 Mar;36(3):198-206.
OBJECTIVE: In this study, we investigated the possible mechanisms underlying the neuroprotective effects of Coumestrol, a potent isoflavonoid with antioxidant activities and binding affinities for both estrogen receptors (ER) ER-alpha and ER-beta that are comparable to those of 17beta-estradiol, in a model of global ischemia in male subjects. METHODS: Wistar rats underwent global ischemia (10 minutes) or sham surgery and received a single intracerebroventricular (icv) infusion of 20 mug of Coumestrol or vehicle 1 hour before ischemia or 0, 3, 6, or 24 hours after reperfusion. RESULTS: The data analysis revealed an extensive neuronal death in the CA1 hippocampal subfield at 7 days, and a significant decrease in the Na+, K+ -ATPase activity at 1 and 24 hours after ischemia, and both injuries were attenuated by Coumestrol administration. CONCLUSIONS: Coumestrol treatment was effective in preventing neuronal loss in all times of administration as well as able to rescue the Na+, K+ -ATPase activity, suggesting its potential benefits for either prevention or therapeutics use against cerebral ischemia in males.